| |
|
|
| |
|
|
| |
| |
hum-molgen: events in
bioscience and medicine |
|
| |
October, 28 2026 |
your calendar for events in genetics, biotechnology
and medicine |
|
| |
|
|
|
|
|
|
| |
advertisement |
|
search meetings |
|
recent postings |
|
|
|
|
| |
=> advertise at hum-molgen
|
|
|
|
| - |
Applied AI and electronic health records (EHR) can strengthen patient recruitment by improving patient identification and providing clinical trial sites with a consolidated view of candidate eligibili: Reduce Patient Recruitment Delays With EHR and Applied AI |
| - |
Serialization has helped pharmaceutical packaging lines meet compliance requirements, but it has also introduced operational challenges for many manufacturers and CMOs. Codes that fail to meet grading: Improve Pharmaceutical Packaging Throughput With Serialization |
| - |
Inflammatory skin diseases such as psoriasis, hidradenitis suppurativa and atopic dermatitis extend beyond the skin, with growing evidence linking these conditions to obesity, metabolic dysfunction, s: Improve Inflammatory Skin Disease Trials Beyond Immune Targets |
| - |
Regulators increasingly want to see the patient voice included to inform drug development and qualitative in-trial patient interviews provide valuable insights into patient experiences that can suppor: Improve Pharmacovigilance Compliance in In-Trial Patient Interviews |
| - |
This webinar is the second in a four-part series from Bioculture and EARA examining the science, regulation and responsibility behind the use of non-human primates (NHPs) in biomedical research. The s: Strengthen Preclinical Evidence for New Therapies Using NHP Research |
| - |
Reliable capsid titer measurement is one of the most critical analytical requirements in AAV gene therapy development. However, moving a titer assay from development to a GMP-regulated quality control: Reduce AAV Gene Therapy GMP Risks With Regulatory-Ready Titer Assays |
| - |
Thrombolysis and thrombectomy have transformed acute ischemic stroke care, yet the need for therapies that improve recovery and reduce disability remains. For small and mid-sized biotech companies dev: Beyond Thrombolysis and Thrombectomy: Designing and Conducting Successful Stroke Clinical Trials |
| - |
As nucleic acid therapeutics advance, researchers increasingly need tools that provide more than confirmation of target engagement or tissue exposure. Understanding the localization and distribution o: Advances in Nucleic Acid Therapeutics Detection and Biological Imaging (Broadcast 1) |
| - |
As nucleic acid therapeutics advance, researchers increasingly need tools that provide more than confirmation of target engagement or tissue exposure. Understanding the localization and distribution o: Advances in Nucleic Acid Therapeutics Detection and Biological Imaging (Broadcast 2) |
| - |
Real-world data (RWD) is increasingly used to support clinical development, safety evaluation and regulatory evidence generation. However, converting electronic health records, claims and registry dat: Use AI to Accelerate RWD Transformation for Regulatory Submissions |
 Get the latest news as RSS feed
|
|
| |
|
|
|
|
|
|
| |
news alert (free) |
|
write an announcement |
|
other resources |
|
| |
|
|
|
|
|
|
| |
To receive our regular news
alert (free - including summary of recent position postings) please register at our
bulletin board.
|
|
Please use our webform for direct postings after you have been set up your account.
By using this site you reach more than
8.000 news alert subscribers and 150.000 HUM-MOLGEN web users and
several mirror sites (e.g. Calender
of Events) in the US, China, Israel and France.
To further improve "hum-molgen: events in bioscience and
medicine" we have redesigned our database and web submission
form. The updated version enables the set up of accounts. By this
way advertisers are in the position to change postings and to submit
multiple postings more efficient. Please report potential problems
/ suggestions for further improvements to the www administrator Kai Garlipp (kai+www@garlipp.de).
|
|
HGMIS Calendar
of Genetic Meetings and Training
Calendar
LifeSciencesInfo.com
How to
Attend a Meeting by Dave Barry
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995-2026 HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|